Banu Arun

Trials

Studies that name Banu Arun as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:06 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT05694559 · Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

  M.D. Anderson Cancer Center · recruiting · Breast Cancer, Colorectal Cancer · principal investigator
• N/A
  NCT05126810 · Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling

  M.D. Anderson Cancer Center · recruiting · Li-Fraumeni Syndrome · principal investigator
• Ph2
  NCT04090567 · Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

  M.D. Anderson Cancer Center · recruiting · Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 · principal investigator
• Ph2
  NCT03063619 · Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast

  M.D. Anderson Cancer Center · completed · Mammographically Dense Breast · principal investigator
• Ph2
  NCT01471106 · Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

  M.D. Anderson Cancer Center · completed · Breast Cancer · principal investigator
• N/A
  NCT01207635 · Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer

  M.D. Anderson Cancer Center · completed · Breast Cancer · study chair
• Ph1
  NCT00637481 · A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

  National Cancer Institute (NCI) · completed · Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ · principal investigator
• Ph2
  NCT00338728 · Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer

  M.D. Anderson Cancer Center · completed · Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive · principal investigator
• Ph1/Ph2
  NCT00100750 · Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer

  National Cancer Institute (NCI) · completed · Recurrent Breast Carcinoma, Stage IV Breast Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:06 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Biomarker modulation/COX-2 inhibitor/Breast Cancer
  R03CA097557 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2002 to 2003 · $75,500 awarded in 2003
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Experimental Medicine Program
  P30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FUNDA MERIC-BERNSTAM · fiscal years 2013 to 2026
  Named on NCT00637481, NCT00338728, NCT00100750